Sirtratumab vedotin
Based on 1 Customer Validation
Sirtratumab vedotin (ASG15-ME) is an ADC composed of a SLITRK6-specific human gamma 2 antibody (Igγ2) conjugated to a small molecule microtubule disrupting agent, monomethyl auristatin E (MMAE) via a protease-cleavable linker.
For research use only. We do not sell to patients.
- Purity: 97.38%
- CAS No.: 1824663-83-3
-
Storage:
-80°C, protect from light
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Sirtratumab vedotin (ASG15-ME) shows high-affinity binding to SLITRK6 expressed on SW780 cells with a Kd of 0.018 nM[1].
Sirtratumab vedotin (10 μg/mL; 1 h) internalizes after binding to SLITRK6[1].
Sirtratumab vedotin (120 h) inhibits CHP-212 cell survival with an IC50 of 0.99 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:CHP-212 and IGR-OV1 cells
-
Concentration:
-
Incubation Time:120 h
-
Result:Showed a dose-dependent inhibition of CHP-212 cell survival with an IC50 of 0.99 nM. Had no effect on IGR-OV1 cells (SLITRK6 negative) when applied at the same concentrations.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:SCID mice, RT4 xenograft model[1]
-
Dosage:5 mg/kg
-
Administration:Intravenous injection, single dose
-
Result:Caused significant inhibition.
-
Animal Model:SCID mice, AG-B7 and AG-B8 xenograft model[1]
-
Dosage:0.25 and 0.5 mg/kg
-
Administration:Intravenous injection, 2x per week for 2 or 3 weeks
-
Result:Significantly reduced tumor volume.
-
Animal Model:SCID mice, the lung xenograft model NCI-H322M[1]
-
Dosage:3 mg/kg
-
Administration:Intravenous injection, 2x per week for 3 weeks
-
Result:Was able to cause 99% tumor growth inhibition.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1824663-83-3
-
Appearance Liquid
-
Color Colorless to light yellow
-
SMILES
[Sirtratumab vedotin]
-
Synonyms
AGS15E; ASG-15ME; 1vcMMAE
-
Shipping
Shipping with dry ice.
-
Storage
-80°C, protect from light
Purity & Documentation
-
Data Sheet (268 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz